To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus	Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus	Recruiting	Phase 2	2026-09-17		NCT07447986

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hangzhou Sumgen Biotech Co., Ltd.	8

40 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Changzhou Second People's Hospital	Changzhou	China	3
Dalian Municipal Central Hospital	Dalian	China	4
GanSu Provincial Hospital	Lanzhou	China	6
Hebei General Hospital	Shijiazhuang	China	7
Hebei Zhongyuan Petrolium Central Hospital	Langfang	China	1
Heping Hospital Affiliated to Changzhi Medical College	Changzhi	China	6
Huzhou Third People's Hospital	Huzhou	China	4
Jilin Provincial People's Hospital	Changchun	China	3
Jilin University First Hospital	Changchun	China	2
Jingzhou Central Hospital	Jingzhou	China	9
Jining First People's Hospital	Jining	China	9
Linfen Central Hospital	Linfen	China	10
Luoyang Central Hospital	Luoyang	China	8
Northern Jiangsu People's Hospital	Yangzhou	China	11
Peking University People's Hospital	Beijing	China	44
People's Hospital of Zhengzhou	Zhengzhou	China	4
Pingxiang People's Hospital	Pingxiang	China	1
Second Hospital of Shanxi Medical University	Taiyuan	China	7
Shanxi Bethune Hospital	Taiyuan	China	26
Shenzhen People's Hospital	Shenzhen	China	25
Shiyan People's Hospital	Shiyan	China	8
The 2nd Affiliated Hospital of Harbin Medical University	Harbin	China	5
The Central Hospital of Wuhan	Wuhan	China	7
The First Affiliated Hospital of Gannan Medical University	Ganzhou	China	1
The First Affiliated Hospital of Guangxi Medical University	Nanning	China	33

Clinical trials